48
D. Li et al.
References
1. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W
(2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc
Natl Acad Sci 103:11838
2. Lin H, Li S, Wang J, Chu C, Zhang Y, Pang X, others (2019) A single-step multi-level
supramolecular system for cancer sonotheranostics. Nanoscale Horizons 4:190–195. https://
doi.org/10.1039/C8NH00276B
3. Zhang J, Zhang J, Li W, Chen R, Zhang Z, Zhang W, Tang Y, Chen X, Liu G, Lee C-S (2017)
Degradable hollow mesoporous silicon/carbon nanoparticles for photoacoustic imaging-guided
highly effective chemo-thermal tumor therapy in vitro and in vivo. Theranostics 7:3007–3020
4. Zhang P, Wang J, Chen H, Zhao L, Chen B, Chu C, Liu H, Qin Z, Liu J, Tan Y, Chen X, Liu
G (2018) Tumor microenvironment-responsive ultrasmall nanodrug generators with enhanced
tumor delivery and penetration. J Am Chem Soc 140:14980–14989
5. Beyer L, Meyer-Wilmes, J, Schönecker S, Schnabel J, Brendel E, Prix C, others (2018) Clinical routine FDG-PET imaging of suspected progressive supranuclear palsy and corticobasal
degeneration: a gatekeeper for subsequent Tau-PET imaging? Front Neurol 9:483–483
6. Bouvier-Muller A, Duconge F (2018) Application of aptamers for in vivo molecular imaging
and theranostics. Adv Drug Deliv Rev 134:94–106
7. Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, Zhang Y, Li W, Zhang X, Chen X,
Liu G (2018) Genetically engineered liposome-like nanovesicles as active targeted transport
platform. Adv Mater 30:1705350
8. Liu X, Yuan L, Zhang L, Mu Y, Li X, Liu C et al (2018) Bioinspired artificial nanodecoys for
Hepatitis B virus. Angew Chem 130:12679–12683
9. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA (1997) Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold
nanoparticles. Science 277:1078–1081
10. Famulok M, Hartig JS, Mayer G (2007) Functional aptamers and aptazymes in biotechnology,
diagnostics, and therapy. ChemInform 38
11. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands.
Nature 346:818–822
12. Brown AK, Liu J, He Y, Lu Y (2009) Biochemical characterization of a Uranyl Ion-Specific
DNAzyme. ChemBioChem 10:486–492
13. Dougherty CA, Cai W, Hong H (2015) Applications of aptamers in targeted imaging: state of
the art. Curr Top Med Chem 15:1138–1152
14. Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T (2018) Tumor
targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38
15. Jacobson O, Chen X (2013) Interrogating tumor metabolism and tumor microenvironments
using molecular positron emission tomography imaging. theranostic approaches to improve
therapeutics. Pharmacol Rev 65:1214–1256
16. Ryu JS, Kim JS, Moon DH, Kim SM, Lee HK (2002) Bone SPECT is more sensitive than MRI
in the detection of early osteonecrosis of the femoral head after renal transplantation. J Nucl
Med Off Publ Soc Nucl Med 43:1006–1011
17. Wang J, Maurer L (2005) Positron emission tomography: applications in drug discovery and
drug development. Curr Top Med Chem 5:1053–1075
18. Charlton J, Sennello J, Smith D (1997) In vivo imaging of inflammation using an aptamer
inhibitor of human neutrophil elastase. Chem Biol 4:809–816
19. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook
G, Warren S (2006) Tumor targeting by an aptamer. J Nucl Med 47:668–678
20. Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, Parma D, Schmidt PG, Warren S
(2001) Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem
276:48644–48654
21. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD et al (2020) MUC1-C regulates
lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun 11:338
D. Li et al.
References
1. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W
(2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc
Natl Acad Sci 103:11838
2. Lin H, Li S, Wang J, Chu C, Zhang Y, Pang X, others (2019) A single-step multi-level
supramolecular system for cancer sonotheranostics. Nanoscale Horizons 4:190–195. https://
doi.org/10.1039/C8NH00276B
3. Zhang J, Zhang J, Li W, Chen R, Zhang Z, Zhang W, Tang Y, Chen X, Liu G, Lee C-S (2017)
Degradable hollow mesoporous silicon/carbon nanoparticles for photoacoustic imaging-guided
highly effective chemo-thermal tumor therapy in vitro and in vivo. Theranostics 7:3007–3020
4. Zhang P, Wang J, Chen H, Zhao L, Chen B, Chu C, Liu H, Qin Z, Liu J, Tan Y, Chen X, Liu
G (2018) Tumor microenvironment-responsive ultrasmall nanodrug generators with enhanced
tumor delivery and penetration. J Am Chem Soc 140:14980–14989
5. Beyer L, Meyer-Wilmes, J, Schönecker S, Schnabel J, Brendel E, Prix C, others (2018) Clinical routine FDG-PET imaging of suspected progressive supranuclear palsy and corticobasal
degeneration: a gatekeeper for subsequent Tau-PET imaging? Front Neurol 9:483–483
6. Bouvier-Muller A, Duconge F (2018) Application of aptamers for in vivo molecular imaging
and theranostics. Adv Drug Deliv Rev 134:94–106
7. Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, Zhang Y, Li W, Zhang X, Chen X,
Liu G (2018) Genetically engineered liposome-like nanovesicles as active targeted transport
platform. Adv Mater 30:1705350
8. Liu X, Yuan L, Zhang L, Mu Y, Li X, Liu C et al (2018) Bioinspired artificial nanodecoys for
Hepatitis B virus. Angew Chem 130:12679–12683
9. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA (1997) Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold
nanoparticles. Science 277:1078–1081
10. Famulok M, Hartig JS, Mayer G (2007) Functional aptamers and aptazymes in biotechnology,
diagnostics, and therapy. ChemInform 38
11. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands.
Nature 346:818–822
12. Brown AK, Liu J, He Y, Lu Y (2009) Biochemical characterization of a Uranyl Ion-Specific
DNAzyme. ChemBioChem 10:486–492
13. Dougherty CA, Cai W, Hong H (2015) Applications of aptamers in targeted imaging: state of
the art. Curr Top Med Chem 15:1138–1152
14. Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T (2018) Tumor
targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38
15. Jacobson O, Chen X (2013) Interrogating tumor metabolism and tumor microenvironments
using molecular positron emission tomography imaging. theranostic approaches to improve
therapeutics. Pharmacol Rev 65:1214–1256
16. Ryu JS, Kim JS, Moon DH, Kim SM, Lee HK (2002) Bone SPECT is more sensitive than MRI
in the detection of early osteonecrosis of the femoral head after renal transplantation. J Nucl
Med Off Publ Soc Nucl Med 43:1006–1011
17. Wang J, Maurer L (2005) Positron emission tomography: applications in drug discovery and
drug development. Curr Top Med Chem 5:1053–1075
18. Charlton J, Sennello J, Smith D (1997) In vivo imaging of inflammation using an aptamer
inhibitor of human neutrophil elastase. Chem Biol 4:809–816
19. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook
G, Warren S (2006) Tumor targeting by an aptamer. J Nucl Med 47:668–678
20. Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, Parma D, Schmidt PG, Warren S
(2001) Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem
276:48644–48654
21. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD et al (2020) MUC1-C regulates
lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun 11:338